Kapoten

Capoten: an angiotensin-converting enzyme inhibitor for the treatment of hypertension and other diseases

Capoten (captopril) is an angiotensin-converting enzyme (ACE) inhibitor that is used to treat hypertension and other cardiovascular diseases. The capoten was developed by Bristol-Myers Squibb and is produced by various manufacturers in different countries of the world, including Russia.

Capoten belongs to a class of antihypertensive drugs that lower blood pressure and reduce the load on the cardiovascular system. It works by blocking ACE, which leads to lower levels of angiotensin II, a substance that causes blood vessels to constrict. This leads to the expansion of blood vessels and a decrease in pressure in them.

Capoten is available in the form of tablets of various dosages (12.5 mg, 25 mg and 50 mg) and can be used either as monotherapy or in combination with other antihypertensive agents.

In addition to arterial hypertension, Capoten can be used to treat congestive heart failure, cardiomyopathy, left ventricular dysfunction in stable condition in patients after myocardial infarction and diabetic nephropathy due to type 1 diabetes mellitus.

Despite the effectiveness of Capoten in the treatment of various diseases, it has a number of contraindications and restrictions for use. These include hypersensitivity to the active substance, the presence of anamnestic information about the development of Quincke's edema with previous prescription of ACE inhibitors, primary hyperaldosteronism, pregnancy, breastfeeding and other conditions. Some side effects may affect the nervous system, cardiovascular and blood systems, and the respiratory system.

In general, Capoten is an effective and widely used drug for the treatment of arterial hypertension and other diseases of the cardiovascular system. However, before using it, it is necessary to discuss all indications and contraindications with your doctor.